kidney outcomes

4 · 20 / page

Ask MedXY AI

Latest news

Tag

Diabetes & Endocrinologycardio-kidney-metabolic diseasesemaglutide

Pooled Analysis of SELECT, FLOW, and SOUL Links Semaglutide to Reduced Kidney Outcomes

By MedXY|Aug 8, 2026

A prespecified pooled analysis of three phase 3 trials including 30,787 participants found semaglutide reduced major kidney outcomes versus placebo, with a 16% relative risk reduction in the primary composite and a favourable safety profile across cardio-kidney-metabolic disease.

Comprehensive Summary of the FINEARTS-HF Trial Results on Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Cardiologyejection fractionFINEARTS-HF

kidney outcomes

Latest news

Pooled Analysis of SELECT, FLOW, and SOUL Links Semaglutide to Reduced Kidney Outcomes

Comprehensive Summary of the FINEARTS-HF Trial Results on Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

Sustained Cardiovascular Health in Young Adulthood Significantly Reduces Midlife Cardiovascular and Kidney Risks

Examining the Link Between Obesity and Kidney Outcomes in Heart Failure with Preserved Ejection Fraction